Taat Global Alternatives company is planning to acquire a smartphone application called "Break Free" from Boksburg Ventures. The application is designed to provide smoking cessation strategies and utilizes advanced technology such as diagnostic modules, augmented and virtual reality psychological health simulations, and day and night rhythm sensors to help adult smokers personalize and customize the use of cessation devices.
Taat anticipates that Break Free can play a strategic role in the market position of its flagship product, TAAT®, which is a nicotine- and tobacco-free cigarette alternative. Currently sold in thousands of retail stores across the United States and online through the TryTAAT.com shopping portal.
The Taat plan involves integrating other patented features and developing an application for use on Android and iOS smartphones by consumers. Following the proposed deal, Taat will issue approximately 17 million common shares of Taat to Boksburg, with each share valued at $0.3225 and $3.6 million in operating funds.
Reference:
Taat, a company in the tobacco industry, has announced plans to acquire a mobile application designed to help people quit smoking.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
